NASCIMBENI, ANNA CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.078
EU - Europa 141
AS - Asia 103
Totale 1.322
Nazione #
US - Stati Uniti d'America 1.075
CN - Cina 62
IT - Italia 48
FI - Finlandia 21
SG - Singapore 21
SE - Svezia 18
VN - Vietnam 16
GB - Regno Unito 14
UA - Ucraina 14
DE - Germania 11
DK - Danimarca 3
FR - Francia 3
IE - Irlanda 3
IN - India 3
NL - Olanda 3
BE - Belgio 2
CA - Canada 2
MX - Messico 1
RO - Romania 1
TR - Turchia 1
Totale 1.322
Città #
Chandler 184
Fairfield 137
Ann Arbor 87
Woodbridge 65
Jacksonville 58
Ashburn 57
Cambridge 54
Seattle 52
Houston 49
Wilmington 43
Princeton 28
New York 25
Des Moines 18
Roxbury 18
San Diego 18
Dong Ket 16
Medford 16
Guangzhou 15
Beijing 14
Boardman 12
Helsinki 12
Singapore 11
Padova 10
Nanjing 7
Cagliari 6
Turin 5
Chicago 4
Milan 4
Bologna 3
Copenhagen 3
Dublin 3
Hefei 3
Kharkiv 3
Shanghai 3
Susegana 3
Tianjin 3
Florence 2
Hebei 2
Las Vegas 2
Lodi 2
Menlo Park 2
Nanchang 2
Norwalk 2
Redmond 2
Redwood City 2
Shenyang 2
Stella Cilento 2
Waanrode 2
Zhengzhou 2
Acton 1
Anaheim 1
Belfast 1
Borås 1
Boston 1
Chengdu 1
Clifton 1
Council Bluffs 1
Düsseldorf 1
Forest City 1
Fuzhou 1
Galati 1
Islington 1
Istanbul 1
Jiaxing 1
Jinan 1
Langfang 1
Lappeenranta 1
Los Angeles 1
Mahbubnagar 1
Mcallen 1
Mexico City 1
Montréal 1
Ogden 1
Pescara 1
Portland 1
Rockville 1
Rome 1
Segrate 1
Tappahannock 1
Toronto 1
Venezia 1
Yellow Springs 1
Totale 1.108
Nome #
Cardioembolic stroke in Danon disease. 134
Autophagy dysregulation in Danon disease 119
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease 105
Study of Muscle Autophagy and Atrophy Markers in Different Phenotypes of Pompe Disease 103
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). 101
Therapeutic advances in the management of Pompe disease and other metabolic myopathies 97
Phenotype modulators in myophosphorylase deficiency 79
Adult acid maltase deficiency: an open trial with albuterol and branched- chain aminoacids 77
Glycogenosys type II and Danon Disease: molecular study and muscle pathology 75
Multisystemic LAMP-2 defect in Danon disease. 67
Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression 59
Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E. 52
Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations 49
The frequency of limb girdle muscular dystrophy 2A in northeastern Italy 39
Muscle atrophy in Limb Girdle Muscular Dystrophy 2A: A morphometric and molecular study 33
Dominant muscular dystrophy with a novel SYNE1 gene mutation 33
Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy 28
Muscle atrophy, ubiquitin-proteasome, and autophagic pathways in dysferlinopathy 27
Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy 22
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 19
Morphological changes in late onset acid Maltase deficient patients with splicing gene mutation 17
Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency. 6
Totale 1.341
Categoria #
all - tutte 5.420
article - articoli 5.079
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020188 0 10 4 8 23 17 23 30 24 24 14 11
2020/2021190 6 13 8 18 15 20 3 17 34 12 23 21
2021/2022266 5 10 27 39 8 18 15 24 12 8 37 63
2022/2023340 57 43 10 45 51 46 2 17 49 4 13 3
2023/2024147 2 22 24 15 1 33 1 7 5 12 16 9
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.341